An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

The FDA approved Johnson & Johnson's Spravato, a ketamine-based nasal spray, to treat adults with major depressive disorder ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

Celebrities like Matthew Perry, Chrissy Teigen and others have been open about using ketamine infusion therapy to help treat mental health conditions. According to the United States Drug ...

Hello, I am a board-certified Psychiatric Nurse Practitioner and a provider at Sterlla Mental Health's Boston Clinic. I am experienced in working with individuals across the lifespan, in both a ...

Our ideal client is someone who is seeking a transformative approach to mental health care. Whether you're struggling with treatment-resistant depression, anxiety, PTSD, or other mood disorders ...

The company also hired a new CEO. Hope Therapeutics plans to acquire Kadima Neuropsychiatry Institute. Kadima will be the flagship for interventional psychiatry clinics. Dr. David Feifel will join ...